TrialAntimicrobial agents and chemotherapy2022

First-in-Human Clinical Trial to Assess the Safety, Tolerability and Pharmacokinetics of Single Doses of NTM-1633, a Novel Mixture of Monoclonal Antibodies against Botulinum Toxin E.

S M Raja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.